{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:55:13Z","timestamp":1793850913512,"version":"4.6.1"},"reference-count":172,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) represents the hepatic expression of the metabolic syndrome and is the most prevalent liver disease. NAFLD is associated with liver-related and extrahepatic morbi-mortality. Among extrahepatic complications, cardiovascular disease (CVD) is the primary cause of mortality in patients with NAFLD. The most frequent clinical expression of CVD is the coronary artery disease (CAD). Epidemiological data support a link between CAD and NAFLD, underlain by pathogenic factors, such as the exacerbation of insulin resistance, genetic phenotype, oxidative stress, atherogenic dyslipidemia, pro-inflammatory mediators, and gut microbiota. A thorough assessment of cardiovascular risk and identification of all forms of CVD, especially CAD, are needed in all patients with NAFLD regardless of their metabolic status. Therefore, this narrative review aims to examine the available data on CAD seen in patients with NAFLD, to outline the main directions undertaken by the CVD risk assessment and the multiple putative underlying mechanisms implicated in the relationship between CAD and NAFLD, and to raise awareness about this underestimated association between two major, frequent and severe diseases.<\/jats:p>","DOI":"10.3390\/life12081189","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T02:12:39Z","timestamp":1659665559000},"page":"1189","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-5491","authenticated-orcid":false,"given":"Georgiana-Diana","family":"Cazac","sequence":"first","affiliation":[{"name":"Unit of Diabetes, Nutrition and Metabolic Diseases, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Clinical Center of Diabetes, Nutrition and Metabolic Diseases, \u201cSt. Spiridon\u201d County Clinical Emergency Hospital, 700111 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-5901","authenticated-orcid":false,"given":"Cristina-Mihaela","family":"L\u0103c\u0103tu\u0219u","sequence":"additional","affiliation":[{"name":"Unit of Diabetes, Nutrition and Metabolic Diseases, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Clinical Center of Diabetes, Nutrition and Metabolic Diseases, \u201cSt. Spiridon\u201d County Clinical Emergency Hospital, 700111 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-9224","authenticated-orcid":false,"given":"C\u0103t\u0103lina","family":"Mihai","sequence":"additional","affiliation":[{"name":"Institute of Gastroenterology and Hepatology, \u201cSf. Spiridon\u201d Emergency Hospital, 700111 Ia\u0219i, Romania"},{"name":"Unit of Medical Semiology and Gastroenterology, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7721-554X","authenticated-orcid":false,"given":"Elena-Daniela","family":"Grigorescu","sequence":"additional","affiliation":[{"name":"Unit of Diabetes, Nutrition and Metabolic Diseases, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Onofriescu","sequence":"additional","affiliation":[{"name":"Unit of Diabetes, Nutrition and Metabolic Diseases, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Clinical Center of Diabetes, Nutrition and Metabolic Diseases, \u201cSt. Spiridon\u201d County Clinical Emergency Hospital, 700111 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0413-026X","authenticated-orcid":false,"given":"Bogdan-Mircea","family":"Mihai","sequence":"additional","affiliation":[{"name":"Unit of Diabetes, Nutrition and Metabolic Diseases, \u201cGrigore T. Popa\u201d University of Medicine and Pharmacy, 700115 Ia\u0219i, Romania"},{"name":"Clinical Center of Diabetes, Nutrition and Metabolic Diseases, \u201cSt. Spiridon\u201d County Clinical Emergency Hospital, 700111 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global Epidemiology of Nonalcoholic Fatty Liver Disease\u2014Meta-analytic Assessment of Prevalence, Incidence, and Outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100305","DOI":"10.1016\/j.jhepr.2021.100305","article-title":"Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"3","author":"Younossi","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","article-title":"Fatty Liver","volume":"28","author":"Kotronen","year":"2008","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: A multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3350\/cmh.2020.0239","article-title":"Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease","volume":"27","author":"Wijarnpreecha","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Duell, P.B., Welty, F.K., Miller, M., Chait, A., Hammond, G., Ahmad, Z., Cohen, D.E., Horton, J.D., Pressman, G.S., and Toth, P.P. (2022). Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement from the American Heart Association. Arter. Thromb. Vasc. Biol., 42.","DOI":"10.1161\/ATV.0000000000000153"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MEG.0000000000000254","article-title":"Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease","volume":"27","author":"Luo","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"l5367","DOI":"10.1136\/bmj.l5367","article-title":"Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: Findings from matched cohort study of 18 million European adults","volume":"367","author":"Alexander","year":"2019","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MEG.0000000000001183","article-title":"Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction","volume":"30","author":"Olubamwo","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jcmg.2016.10.024","article-title":"Pericardial, But Not Hepatic, Fat by CT Is Associated with CV Outcomes and Structure","volume":"10","author":"Shah","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1440-1746.2012.07222.x","article-title":"Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese","volume":"27","author":"Liu","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.atherosclerosis.2015.02.011","article-title":"The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"239","author":"Silverman","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4236\/ijcm.2020.114018","article-title":"Non-Alcoholic Fatty Liver Disease as a Coronary Heart Disease Severity Predictor","volume":"11","author":"Ismael","year":"2020","journal-title":"Int. J. Clin. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11739-012-0826-5","article-title":"Nonalcoholic fatty liver disease and atherosclerosis","volume":"7","author":"Gaudio","year":"2012","journal-title":"Intern. Emerg. Med."},{"key":"ref_21","first-page":"201","article-title":"Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease","volume":"12","author":"Sharifi","year":"2016","journal-title":"ARYA Atheroscler."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fmed.2019.00202","article-title":"Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis\u2014Literature Review","volume":"6","author":"Ismaiel","year":"2019","journal-title":"Front. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cld.1017","article-title":"Nonalcoholic Fatty Liver Disease and Cardiovascular Disease","volume":"17","author":"Przybyszewski","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1253\/circj.72.618","article-title":"Evaluation of Vulnerable Coronary Plaques and Non-Alcoholic Fatty Liver Disease (NAFLD) by 64-Detector Multislice Computed Tomography (MSCT)","volume":"72","author":"Akabame","year":"2007","journal-title":"Circ. J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chen, C.-C., Hsu, W.-C., Wu, H.-M., Wang, J.-Y., Yang, P.-Y., and Lin, I.-C. (2021). Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification. Medicina, 57.","DOI":"10.3390\/medicina57080807"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.25593","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2012.07.002","article-title":"Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: The Shanghai Changfeng study","volume":"224","author":"Li","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.aohep.2020.09.006","article-title":"Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease","volume":"19","author":"Arab","year":"2020","journal-title":"Ann. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis","volume":"11","author":"Hamdeh","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10554-015-0587-0","article-title":"Prevalence of coronary atherosclerosis in an Asian population: Findings from coronary computed tomographic angiography","volume":"31","author":"Park","year":"2015","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the Vulnerable Plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1148\/radiol.11101725","article-title":"Effect of Metabolic Syndrome on Coronary Artery Stenosis and Plaque Characteristics as Assessed with 64\u2013Detector Row Cardiac CT","volume":"261","author":"Lim","year":"2011","journal-title":"Radiology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.cgh.2020.07.030","article-title":"Association of Hepatic Steatosis with Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease","volume":"19","author":"Meyersohn","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.3748\/wjg.v19.i38.6453","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans","volume":"19","author":"Choi","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_35","unstructured":"Toh, J.Z.K., Pan, X.-H., Tay, P.W.L., Ng, C.H., Yong, J.N., Xiao, J., Koh, J.H., Tan, E.Y., Tan, E.X.X., and Dan, Y.Y. (Clin. Gastroenterol. Hepatol., 2021). A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease, Clin. Gastroenterol. Hepatol., in press."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jhep.2017.12.012","article-title":"Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study","volume":"68","author":"Lee","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ehjci\/jev325","article-title":"Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: A systematic review and meta-analysis","volume":"17","author":"Thomsen","year":"2015","journal-title":"Eur. Hear. J. Cardiovasc. Imaging"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Niikura, T., Imajo, K., Ozaki, A., Kobayashi, T., Iwaki, M., Honda, Y., Kessoku, T., Ogawa, Y., Yoneda, M., and Kirikoshi, H. (2020). Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver. Diagnostics, 10.","DOI":"10.3390\/diagnostics10030129"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic Fatty Liver Disease and Fibrosis Associated with Increased Risk of Cardiovascular Events in a Prospective Study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.14637","article-title":"The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population","volume":"41","author":"Hsu","year":"2020","journal-title":"Liver Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1148\/radiol.14140933","article-title":"High-Risk Coronary Plaque at Coronary CT Angiography Is Associated with Nonalcoholic Fatty Liver Disease, Independent of Coronary Plaque and Stenosis Burden: Results from the ROMICAT II Trial","volume":"274","author":"Puchner","year":"2015","journal-title":"Radiology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101215","DOI":"10.1016\/j.diabet.2020.101215","article-title":"NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment","volume":"47","author":"Targher","year":"2020","journal-title":"Diabetes Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/hep.28253","article-title":"Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study","volume":"63","author":"Wong","year":"2015","journal-title":"Hepatology"},{"key":"ref_44","first-page":"949","article-title":"Changes in inflammatory factors and prognosis of patients complicated with non-alcoholic fatty liver disease undergoing coronary artery bypass grafting","volume":"15","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Th\u00e9venot, T., Vendeville, S., Weil, D., Akkouche, L., Calame, P., Canivet, C.M., Vanlemmens, C., Richou, C., Cervoni, J.-P., and Seronde, M.-F. (2022). Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0266965"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e3333","DOI":"10.1002\/dmrr.3333","article-title":"Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance","volume":"36","author":"Fiorentino","year":"2020","journal-title":"Diabetes\/Metabolism Res. Rev."},{"key":"ref_47","first-page":"4688","article-title":"A Correlation Study between Non-Alcoholic Fatty Liver Disease and Severity of Coronary Artery Disease","volume":"8","author":"Jana","year":"2020","journal-title":"J. Med Sci. Clin. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e00011","DOI":"10.14309\/ctg.0000000000000011","article-title":"Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients with Stable Coronary Artery Disease: A Matched Case\u2013Control Study","volume":"10","author":"Liu","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2478\/rjim-2018-0009","article-title":"The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography","volume":"56","author":"Langroudi","year":"2018","journal-title":"Romanian J. Intern. Med."},{"key":"ref_50","first-page":"118","article-title":"Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetic Patients in Correlation with Coronary Artery Disease","volume":"3","author":"Pulimaddi","year":"2016","journal-title":"Int. Arch. Integr. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gutjnl-2016-311854","article-title":"Non-alcoholic fatty liver disease and progression of coronary artery calcium score: A retrospective cohort study","volume":"66","author":"Sinn","year":"2016","journal-title":"Gut"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1753-0407.12172","article-title":"Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: A computed tomography angiography study","volume":"7","author":"Idilman","year":"2014","journal-title":"J. Diabetes"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Osawa, K., Miyoshi, T., Yamauchi, K., Koyama, Y., Nakamura, K., Sato, S., Kanazawa, S., and Ito, H. (2015). Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0131138"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0003319713479155","article-title":"Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease Complexity in Patients with Acute Coronary Syndrome","volume":"64","author":"Korkmaz","year":"2013","journal-title":"Angiology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/met.2012.0149","article-title":"Relationship of Serum Fetuin-A Levels with Coronary Atherosclerotic Burden and NAFLD in Patients Undergoing Elective Coronary Angiography","volume":"11","author":"Ballestri","year":"2013","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.3390\/ijerph10083409","article-title":"Relationship between Retinal Vascular Caliber and Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"10","author":"Josef","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1136\/gut.2011.242016","article-title":"Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.09090769","article-title":"Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease","volume":"254","author":"Assy","year":"2010","journal-title":"Radiology"},{"key":"ref_59","first-page":"273","article-title":"Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography","volume":"9","author":"Sunay","year":"2009","journal-title":"Anadolu Kardiyol. Derg. AKD Anatol. J. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MCA.0b013e3282583c0d","article-title":"Association between nonalcoholic fatty liver disease and coronary artery disease","volume":"18","author":"Arslan","year":"2007","journal-title":"Coron. Artery Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e210260","DOI":"10.1148\/ryct.210260","article-title":"Hepatosteatosis and Atherosclerotic Plaque at Coronary CT Angiography","volume":"4","author":"Carter","year":"2022","journal-title":"Radiol. Cardiothorac. Imaging"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/eurjpc\/zwab120","article-title":"Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease","volume":"28","author":"Ichikawa","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_63","first-page":"1","article-title":"Association between Non-alcoholic Fatty Liver Disease and the Severity of Coronary Artery Stenosis in Eastern Chinese Population","volume":"21","author":"Wang","year":"2022","journal-title":"Zahedan J. Res. Med Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-020-01192-4","article-title":"Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: A prospective cohort study","volume":"20","author":"Ichikawa","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s43044-021-00222-0","article-title":"The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography","volume":"73","author":"Saraya","year":"2021","journal-title":"Egypt. Hear. J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8820445","DOI":"10.1155\/2020\/8820445","article-title":"Association and Prediction of Subclinical Atherosclerosis by Nonalcoholic Fatty Liver Disease in Asymptomatic Patients","volume":"2020","author":"Bae","year":"2020","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jvs.2019.03.044","article-title":"The association between liver fat and systemic calcified atherosclerosis","volume":"71","author":"Koo","year":"2019","journal-title":"J. Vasc. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"620","DOI":"10.14309\/ajg.0000000000000074","article-title":"Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study","volume":"114","author":"Chang","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.amjcard.2019.05.028","article-title":"Nonalcoholic Fatty Liver Disease Is Associated with Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis)","volume":"124","author":"Oni","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.30223","article-title":"Relationship Among Fatty Liver, Specific and Multiple-Site Atherosclerosis, and 10-Year Framingham Score","volume":"69","author":"Pais","year":"2019","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00535-018-1516-5","article-title":"Clinical significance of hepatic steatosis according to coronary plaque morphology: Assessment using controlled attenuation parameter","volume":"54","author":"Park","year":"2018","journal-title":"J. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Gummesson, A., Str\u00f6mberg, U., Schmidt, C., Kullberg, J., Anger\u00e5s, O., Lindgren, S., Hjelmgren, O., Tor\u00e9n, K., Rosengren, A., and Fagerberg, B. (2018). Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202666"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"9933","DOI":"10.1038\/s41598-017-09851-5","article-title":"Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: A Cross Sectional Study","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2016.01.010","article-title":"Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly","volume":"14","author":"Jacobs","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jacl.2016.09.007","article-title":"Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study","volume":"10","author":"Kim","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1210\/jc.2016-1525","article-title":"Nonalcoholic Fatty Liver Disease is Associated with Coronary Artery Calcification Development: A longitudinal study","volume":"101","author":"Park","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/GME.0000000000000503","article-title":"Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women","volume":"22","author":"Kim","year":"2015","journal-title":"Menopause"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3349\/ymj.2015.56.5.1288","article-title":"Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis","volume":"56","author":"Kang","year":"2015","journal-title":"Yonsei Med. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12933-015-0253-9","article-title":"Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: The Kangbuk Samsung Health Study","volume":"14","author":"Lee","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_80","first-page":"10","article-title":"Assessment of the Relationship between Non-Alcoholic Fatty Liver Disease and CAD using MSCT","volume":"102","author":"Efe","year":"2013","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.atherosclerosis.2014.05.962","article-title":"Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study","volume":"235","author":"Ning","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.mayocp.2013.06.025","article-title":"Association of Coronary Artery Calcification with Hepatic Steatosis in Asymptomatic Individuals","volume":"88","author":"Chhabra","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.2337\/dc12-1276","article-title":"Fatty Liver Increases the Association of Metabolic Syndrome with Diabetes and Atherosclerosis","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijcard.2011.05.059","article-title":"Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics","volume":"162","author":"Khashper","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1475-2840-12-162","article-title":"Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort","volume":"12","author":"Sung","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jjcc.2012.05.003","article-title":"The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease","volume":"60","author":"Arslan","year":"2012","journal-title":"J. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2337\/dc12-0515","article-title":"Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome","volume":"35","author":"Sung","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_88","first-page":"351","article-title":"Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes","volume":"59","author":"Agarwal","year":"2011","journal-title":"J. Assoc. Physicians India"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic Fatty Liver Disease 2020: The State of the Disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2006.04.006","article-title":"Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study","volume":"191","author":"Schindhelm","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1097\/HJH.0000000000000763","article-title":"Gamma-glutamyltransferase and risk of hypertension","volume":"33","author":"Kunutsor","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1515\/CCLM.2010.052","article-title":"Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005\u20132006","volume":"48","author":"Webber","year":"2009","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2008.03.039","article-title":"Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999\u20132004","volume":"135","author":"Cheung","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"658","DOI":"10.5009\/gnl18439","article-title":"Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease","volume":"13","author":"Song","year":"2019","journal-title":"Gut Liver"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/07853890.2021.1943514","article-title":"Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999\u20132016","volume":"53","author":"Lee","year":"2021","journal-title":"Ann. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4093\/dmj.2019.0011","article-title":"Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis","volume":"43","author":"Lee","year":"2019","journal-title":"Diabetes Metab. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver (2015). EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol., 63, 237\u2013264.","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic Fibrosis Associates with Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study","volume":"73","author":"Long","year":"2020","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3748\/wjg.v21.i4.1158","article-title":"Factors associated with significant liver fibrosis assessed using transient elastography in general population","volume":"21","author":"You","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_101","first-page":"101580","article-title":"Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients","volume":"45","author":"Xavier","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/echo.13545","article-title":"Diagnosis of fatty liver by computed tomography coronary artery calcium score","volume":"34","author":"Kerut","year":"2017","journal-title":"Echocardiography"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardio-vascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC)","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Niederseer, D., Wernly, S., Bachmayer, S., Wernly, B., Bakula, A., Huber-Sch\u00f6nauer, U., Semmler, G., Schmied, C., Aigner, E., and Datz, C. (2020). Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) Is Independently Associated with Cardiovascular Risk in a Large Austrian Screening Cohort. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041065"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Van Veelen, A., van der Sangen, N.M.R., Delewi, R., Beijk, M.A.M., Henriques, J.P.S., and Claessen, B.E.P.M. (2022). Detection of Vulnerable Coronary Plaques Using Invasive and Non-Invasive Imaging Modalities. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051361"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12944-015-0141-z","article-title":"Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis","volume":"14","author":"Xu","year":"2015","journal-title":"Lipids Heal. Dis."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Caturano, A., Acierno, C., Nevola, R., Pafundi, P.C., Galiero, R., Rinaldi, L., Salvatore, T., Adinolfi, L.E., and Sasso, F.C. (2021). Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact. Processes, 9.","DOI":"10.3390\/pr9010135"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3350\/cmh.2021.0067","article-title":"From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?","volume":"27","author":"Kang","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.jacc.2017.10.024","article-title":"Normal LDL-Cholesterol Levels Are Associated with Subclinical Atherosclerosis in the Absence of Risk Factors","volume":"70","author":"Fuster","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1530\/EC-20-0490","article-title":"Pathophysiology of NASH in endocrine diseases","volume":"10","author":"Gariani","year":"2021","journal-title":"Endocr. Connect."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.3748\/wjg.v20.i26.8407","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease","volume":"20","author":"Liu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"10206","DOI":"10.1038\/ncomms10206","article-title":"Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese","volume":"6","author":"Tang","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00125-019-05024-3","article-title":"Non-alcoholic fatty liver disease and cardiovascular disease: Assessing the evidence for causality","volume":"63","author":"Brouwers","year":"2019","journal-title":"Diabetologia"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2016.12.020","article-title":"PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease","volume":"152","author":"Simons","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Hsieh, C.-J., Wang, P.W., and Hu, T.H. (2015). Association of Adiponectin Gene Polymorphism with Nonalcoholic Fatty Liver Disease in Taiwanese Patients with Type 2 Diabetes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127521"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12944-016-0221-8","article-title":"Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: A concise review","volume":"15","author":"Li","year":"2016","journal-title":"Lipids Heal. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Dong, M., Liu, S., Wang, M., Wang, Y., Xin, Y., and Xuan, S. (2021). Relationship between AGT rs2493132 polymorphism and the risk of coronary artery disease in patients with NAFLD in the Chinese Han population. J. Int. Med Res., 49.","DOI":"10.1177\/03000605211019263"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Pulido, M.R., Diaz-Ruiz, A., Jim\u00e9nez-G\u00f3mez, Y., Garcia-Navarro, S., Gracia-Navarro, F., Tinahones, F., L\u00f3pez-Miranda, J., Fr\u00fchbeck, G., V\u00e1zquez-Mart\u00ednez, R., and Malag\u00f3n, M.M. (2011). Rab18 Dynamics in Adipocytes in Relation to Lipogenesis, Lipolysis and Obesity. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022931"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e000096","DOI":"10.1136\/bmjgast-2016-000096","article-title":"Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease","volume":"3","author":"Mehta","year":"2016","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1194\/jlr.RA120000746","article-title":"Prognostic utility of triglyceride-rich lipoprotein-related markers in patients with coronary artery disease","volume":"61","author":"Cao","year":"2020","journal-title":"J. Lipid Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e13519","DOI":"10.1111\/eci.13519","article-title":"Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches","volume":"51","author":"Dongiovanni","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome\u2014An allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3803\/EnM.2013.28.4.283","article-title":"Association of Serum Adipocyte-Specific Fatty Acid Binding Protein with Fatty Liver Index as a Predictive Indicator of Nonalcoholic Fatty Liver Disease","volume":"28","author":"Jeon","year":"2013","journal-title":"Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e005344","DOI":"10.1161\/JAHA.116.005344","article-title":"Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients with Type 2 Diabetes Mellitus","volume":"6","author":"Lee","year":"2017","journal-title":"J. Am. Hear. Assoc."},{"key":"ref_129","first-page":"861","article-title":"FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss","volume":"36","author":"Domingo","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Hao, Y., Zhou, J., Zhou, M., Ma, X., Lu, Z., Gao, M., Pan, X., Tang, J., Bao, Y., and Jia, W. (2013). Serum Levels of Fibroblast Growth Factor 19 Are Inversely Associated with Coronary Artery Disease in Chinese Individuals. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072345"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hep4.1108","article-title":"Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice","volume":"1","author":"Zhou","year":"2017","journal-title":"Hepatol. Commun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: A clinical review","volume":"110","author":"Kasper","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"155179","DOI":"10.1016\/j.metabol.2022.155179","article-title":"Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease","volume":"130","author":"Baars","year":"2022","journal-title":"Metabolism"},{"key":"ref_135","first-page":"e26818","article-title":"Association of Tumor Necrosis Factor-alpha Polymorphisms and Risk of Coronary Artery Disease in Patients with Non-alcoholic Fatty Liver Disease","volume":"15","author":"Cheng","year":"2015","journal-title":"Zahedan J. Res. Med Sci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2018.01.046","article-title":"Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis","volume":"259","author":"Simon","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1253\/circj.71.1703","article-title":"Hypoadiponectinemia is Associated with Impaired Glucose Tolerance and Coronary Artery Disease in Non-Diabetic Men","volume":"71","author":"Otsuka","year":"2007","journal-title":"Circ. J."},{"key":"ref_138","first-page":"35","article-title":"Nonalcoholic Fatty Liver Disease and the Coronary Artery Disease","volume":"56","author":"Treeprasertsuk","year":"2010","journal-title":"Am. J. Dig. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_140","first-page":"e20515","article-title":"Study of Endothelial Dysfunction in Patients with Non-alcoholic Fatty Liver Disease","volume":"13","author":"Jose","year":"2021","journal-title":"Cureus"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.atherosclerosis.2010.01.049","article-title":"Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis","volume":"211","author":"Yilmaz","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.amjcard.2017.07.107","article-title":"Effect of Nonalcoholic Fatty Liver Disease on In-Hospital and Long-Term Outcomes in Patients With ST\u2013Segment Elevation Myocardial Infarction","volume":"120","author":"Keskin","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Persico, M., Masarone, M., Damato, A., Ambrosio, M., Federico, A., Rosato, V., Bucci, T., Carrizzo, A., and Vecchione, C. (2017). Non alcoholic fatty liver disease and eNOS dysfunction in humans. BMC Gastroenterol., 17.","DOI":"10.1186\/s12876-017-0592-y"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00125-003-1053-4","article-title":"Control of body weight: A physiologic and transgenic perspective","volume":"46","year":"2003","journal-title":"Diabetologia"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1210\/en.2002-220075","article-title":"Leptin Inhibits Angiotensin II-Induced Intracellular Calcium Increase and Vasoconstriction in the Rat Aorta","volume":"143","author":"Salvador","year":"2002","journal-title":"Endocrinology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e3050","DOI":"10.1002\/dmrr.3050","article-title":"Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes","volume":"34","author":"Cernea","year":"2018","journal-title":"Diabetes\/Metabolism Res. Rev."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3748\/wjg.v23.i19.3396","article-title":"Renin angiotensin system in liver diseases: Friend or foe?","volume":"23","author":"Silva","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/jgh.12549","article-title":"Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease","volume":"29","author":"Elsheikh","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"261","DOI":"10.15403\/jgld.2014.1121.263.dal","article-title":"Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study","volume":"26","author":"Dallio","year":"2017","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_150","first-page":"4305","article-title":"Plasma pentraxin-3 is associated with endothelial dysfunction in non-alcoholic fatty liver disease","volume":"20","author":"Gurel","year":"2016","journal-title":"Eur. Rev. Med Pharmacol. Sci."},{"key":"ref_151","first-page":"6613827","article-title":"NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2","volume":"2021","author":"Knobloch","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Sanduzzi Zamparelli, M., Compare, D., Coccoli, P., Rocco, A., Nardone, O.M., Marrone, G., Gasbarrini, A., Grieco, A., Nardone, G., and Miele, L. (2016). The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081225"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Xu, J., Wang, X., Ren, X., and Liu, Y. (2019). Changes of intestinal bacterial microbiota in coronary heart disease complicated with nonalcoholic fatty liver disease. BMC Genom., 20.","DOI":"10.1186\/s12864-019-6251-7"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","article-title":"Symptomatic atherosclerosis is associated with an altered gut metagenome","volume":"3","author":"Karlsson","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"22661","DOI":"10.1038\/s41598-021-02144-y","article-title":"Circulating bile acids concentration is predictive of coronary artery disease in human","volume":"11","author":"Nguyen","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","article-title":"Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide","volume":"35","author":"Wang","year":"2014","journal-title":"Eur. Hear. J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe\u2013targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1111\/jgh.15156","article-title":"Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"35","author":"Lu","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/joim.13069","article-title":"Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999\u20132016","volume":"288","author":"Zou","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"100097","DOI":"10.1016\/j.ajpc.2020.100097","article-title":"The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study","volume":"4","author":"Aneni","year":"2020","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e00326","DOI":"10.14309\/ctg.0000000000000326","article-title":"Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations with Metabolic Dysregulation and Cardiovascular Risk\u2014A Single-Center Cross-Sectional Study","volume":"12","author":"Semmler","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/cd18-0026","article-title":"Patients with Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality","volume":"37","author":"Golabi","year":"2019","journal-title":"Clin. Diabetes"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Bisaccia, G., Ricci, F., Mantini, C., Tana, C., Romani, G.L., Schiavone, C., and Gallina, S. (2020). Nonalcoholic fatty liver disease and cardiovascular disease phenotypes. SAGE Open Med., 8.","DOI":"10.1177\/2050312120933804"},{"key":"ref_164","first-page":"216","article-title":"Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications","volume":"5","author":"Kumar","year":"2017","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"638615","DOI":"10.3389\/fendo.2021.638615","article-title":"The Repeatedly Elevated Fatty Liver Index Is Associated with Increased Mortality: A Population-Based Cohort Study","volume":"12","author":"Lee","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e6712","DOI":"10.1097\/MD.0000000000006712","article-title":"Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease","volume":"96","author":"Yoshitaka","year":"2017","journal-title":"Medicine"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/hepr.12648","article-title":"Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors","volume":"46","author":"Honda","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Kuchay, M.S., Mart\u00ednez-Montoro, J.I., Choudhary, N.S., Fern\u00e1ndez-Garc\u00eda, J.C., and Ramos-Molina, B. (2021). Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101346"},{"key":"ref_169","unstructured":"Tang, A., Ng, C.H., Phang, P.H., Chan, K.E., Chin, Y.H., Fu, C.E., Zeng, R.W., Xiao, J., Tan, D.J.H., and Quek, J. (2022). Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs. Non-Lean NAFLD\u2014A Systematic Review and Meta-Analysis. Clin. Gastroenterol. Hepatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5009\/gnl210084","article-title":"Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease","volume":"16","author":"Kim","year":"2022","journal-title":"Gut Liver"},{"key":"ref_171","first-page":"706","article-title":"Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study","volume":"38","author":"Khan","year":"2017","journal-title":"Liver Int."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2008.07.024","article-title":"The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects","volume":"203","author":"Sung","year":"2009","journal-title":"Atherosclerosis"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/8\/1189\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:03:54Z","timestamp":1760141034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/8\/1189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":172,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["life12081189"],"URL":"https:\/\/doi.org\/10.3390\/life12081189","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]}}}